Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 12/9/25 → 12/9/27 |
Financiación
- Perspective Therapeutics Incorporated: 32.700,00 US$
25-MULTI-69-PSV-PMC (PSV359-001): A Phase I/II Image-Guided, Alpha-Particle Therapy Study of [203Pb]PSV359 and [212Pb]Pb-PSV359 in Patients with Solid Tumors that are Known to be Fibroblast Activation Protein (FAP)-Positive
- Fabian, Denise (PI)